Red Tree Venture Capital
Edit

Red Tree Venture Capital

https://redtreevc.com
Last activity: 03.05.2024
Invests in categories: MedtechTechnologyBioTechDrugDevelopmentHealthTechBuildingFoodTechHardwareLife
Red Tree Venture Capital is an early stage-biased life science venture firm that employs a targeted strategy of leveraging its deep relationships with leading West Coast academic and research institutions to source innovation emerging from those organizations.
News
27
Portfolio
13
Persons
6
Mentions
3
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B

Portfolio 13

DateNameWebsiteTotal RaisedLocation
13.04.2024Engrail Th...engrail.com$253MUnited Sta...
09.02.2024Contineum ...contineum-tx.com--
29.06.2023Tachyon Th...tachyontx.com$11.6MUnited Sta...
10.11.2022Syncopatio...syncopationlife.com$200MUnited Sta...
10.11.2022Cargo Ther...cargo-tx.com--
03.11.2022Bicara The...bicara.com$273MUnited Sta...
02.03.2022Rondo Ther...rondotx.com$67MUnited Sta...
-Acrigen Bi...acrigen.com-United Sta...
-Ceribellceribell.com$138MUnited Sta...
-Alladapt I...alladapt.com$119MUnited Sta...
Show more

Persons 6

DateFirst NameLast NameTitleLinkedInLocation
-JonEdwardsManaging D...linkedin.c...-
-MattPotterCFOlinkedin.c...-
-JodiYangHead of Ca...linkedin.c...-
-KrishnaPoluPrincipallinkedin.c...-
-HeathLukatchFounder &a...linkedin.c...-
-YokoSugimotoExecutive ...linkedin.c...-

News 27

DateTitleDescription
01.05.2024Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System-
01.05.2024MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT® Neuromodulation System to Market-
04.04.2024Contineum Therapeutics Announces Pricing of Initial Public Offering-
19.03.2024Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies-
12.12.2023Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing-
16.11.2023Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red Tree Venture Capital as Partner-
16.11.2023West Coast investor Red Tree on its San Diego expansion and staying bullish in biotech-
09.11.2023CARGO Therapeutics Announces Pricing of Initial Public Offering-
17.04.2023Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307-
06.03.2023Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer-
Show more

Mentions in press and media 3

DateTitleDescription
19.03.2024Engrail Therapeutics raises $157M Series BEngrail Therapeutics, a precision neuroscience company focused on the development of transformational therapies to improve the lives of patients, today announced that it has closed an oversubscribed $157 million Series B financing round. Th...
06.10.2022Red Tree Venture Capital Announces Closing of $272 Million Inaugural Fund-
06.10.2022Red Tree Venture Capital Closes Inaugural Fund, at $272MRed Tree Venture Capital, a West Coast-centric, early stage-biased life science venture capital firm, announced a $272m final close of its inaugural fund, Red Tree Venture Capital Fund I. Founded in 2020 by Heath Lukatch, Ph.D. and Jennifer...

Reviews 0

Sign up to leave a review

Sign up Log In